Kanabo (#KNB) – emphasises 2024 “revenue growth”, but it just to £1.3m resulting in still an even “operating EBITDA loss” of £1.9m

Kanabo (#KNB) – David Tsur to ‘step down’ from the board

Kanabo (#KNB) – “launching an additional 14 in-pharmacy clinics across the UK”, no financials (natch!)

Kanabo (#KNB) – £2.54m bailout equity raise at 2.88p per share with warrants, up to £0.2m “broker option”

Kanabo (#KNB) – 2022 loss £6.9m on revenue of £0.6m, cash down to £3.2m

Kanabo (#KNB) – online medicinal cannabis clinic launch, attempted ramptastic!

Kanabo pumped in the Mail in the Proactive Column - surely this is just dishonest "journalism"

Once a week the investment hookers at Proactive pen a small cap column for the Mail on Sunday. This week’s effort is flagged up below. Nowhere on the column is there any disclaimer to admit that Proactive is paid by companies to publish research. So, readers of the tabloid will assume that this is just good honest impartial journalism. Of course it is anything but. Take this week’s effort below…

Kanabo (#KNB) – argues “significant progress”, but provides no financials

Kanabo (#KNB) – NED Andy Morrison “decided to step down”

Kanabo (#KNB) – 2021 £3.4m operating loss, cash £4.5m

Kanabo (#KNB) – proposed acquisition of Materia off, argues a strategic partnership ‘more effective’

Kanabo (#KNB) – notes guidance on steps required to license an e-cigarette as a medicinal product in UK

Kanabo (#KNB) – H1 revenue just £15k, operating loss £1.2m, cash £5.9m

Kanabo (#KNB) – products available on CBD-dedicated “leading” UK eCommerce site, no financials (natch!)

Kanabo (#KNB) – £1m placing at 22p per share & Hellenic Dynamics agreement and investment

Kanabo – Cannabis Production Agreement but the high is already surely over

Newly (rushed) sub-Standard Listed Kanabo (KNB) has announced a cannabis production agreement with PharmaCann Polska, which is to supply cartiges containing Kanabo’s proprietry medicial cannabis for its VapePod inhalation device. The shares are up by 11% (last seen) on the news, to 20.5p – a long way off the ridiculous (ahem) high of over 40p at the IPO - valuing the company at some £47 million. That’s surely nonsense!

You’d need to be smoking uber strong Ganja to buy this bollocks from joke pot play Kanobo

Shares in Kanabo (KNB) have quadrupled to 25.5p since it raised £6 million as part of an RTO a week ago and this company, with zero sales and perhaps £4 million in the bank, is now valued at £92 million... you’d need to be smoking serious weed to buy that. But now, after just a week, we get the first announcement of just mind-blowing bollocks showing what a total spoof this all is.

The funny old world of....... IPO prospectuses: when half a year vanishes in a puff of smoke

Following on from Tom Winnifrith’s question over IFRS and the accounts of Heavitree Brewery (HVT), I have a question from the similarly funny old world of prospectuses – this is from that fine new outfit now on the sub-Standard list, pot-play Kanabo (KNB) which listed this week and has raced ahead by almost seven-fold.

Kanabo – a new pot IPO flies to the moon but how bad will the hangover be?

There is a flurry of new cannabis listings going on at the moment, and Peterhouse play Kanabo (KNB) joined the Standard List yesterday, having reversed into Spinnaker Opportunities – a cash shell which joined the sub-Standard list back in 2017. The RTO was accompanied by a placing, raising £6 million gross at 6.5p and the stock is, ahem, on a high at 17.25p giving a market capitalisation of a very tasty £62 million. So is it a buy or a bargepole?